Measurement of Glycaemic Responses of Bakery and Confectionery Products
GIFA
1 other identifier
interventional
14
1 country
1
Brief Summary
This study aims to determine the glycemic index, glycemic load and insulin index of eleven Fazer bakery and confectionary products.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Aug 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 14, 2011
CompletedFirst Posted
Study publicly available on registry
October 18, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedFebruary 15, 2012
November 1, 2011
5 months
October 14, 2011
February 14, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Glycemic index (GI)
The 2 hours glycemic responses to bakery and confectionery products (the incremental area under the glucose response curve, IAUC).
Secondary Outcomes (2)
Insulin index (II)
Glycemic load (GL)
Interventions
Control product: Glucose solution, Test products: 11 bakery and confectionary products
Eligibility Criteria
You may qualify if:
- voluntarily given written consent for participation in research
- healthy man or women, age between 18 ang 65 years
- regular eating
- Body Mass Index 18,5 - 24,9 kg/m2
You may not qualify if:
- diabetes
- gastrointestinal diseases
- hepatic, kidney, pancreas or thyroid disease or disorder
- arthritis
- pregnancy or breast feeding
- smoking
- allergy
- severe diseases
- blood donation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clinical Life Sciences Ltd.lead
- Fazercollaborator
Study Sites (1)
Clinical Life Sciences Ltd
Kajaani, 87100, Finland
Study Officials
- PRINCIPAL INVESTIGATOR
Päivi Cheney, MD
- STUDY DIRECTOR
Tiina Suutari, M.Sc.
Clinical Life Sciences Ltd.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2011
First Posted
October 18, 2011
Study Start
August 1, 2011
Primary Completion
January 1, 2012
Study Completion
January 1, 2012
Last Updated
February 15, 2012
Record last verified: 2011-11